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Abstract
In the search for antimalarials from ethnobotanical origin, plant extracts are chemically fractionated and biological
tests guide the isolation of pure active compounds. To establish the responsibility of isolated active compound(s)
to the whole antiplasmodial activity of a crude extract, the literature in this field was scanned and results were
analysed quantitatively to find the contribution of the pure compound to the activity of the whole extract. It was
found that, generally, the activity of isolated molecules could not account on their own for the activity of the
crude extract. It is suggested that future research should take into account the “drugs beside the drug”, looking for
those products (otherwise discarded along the fractionation process) able to boost the activity of isolated active
compounds.
Introduction
In the search for anti-malarial activity of plants tradi-
tionally used against fevers, collected plants are first
submitted to an extraction process with polar or apolar
solvents. Ideally, the extracts are then tested against ery-
throcytic stages of Plasmodium falciparum in vitro to
validate anti-plasmodial activity. Classically, when biolo-
gical tests identify significant activity, crude extracts are
submitted to a bioguided fractionation procedure, aim-
ing to isolate the active compound(s). For that purpose,
several sequential extractions with solvents of diverse
polarities are performed, and purified fractions are sub-
mitted to anti-plasmodial tests and to chemical identifi-
cation. Frequently, many promising extracts are
discarded because the anti-plasmodial activity disappears
along the fractionation process. The failure to isolate
active constituents from active extracts may be due to
the lability/instability of the active compounds that are
degraded during the extraction process. Sometimes, the
loss of activity is due to the fact that the compounds
display their activity only when they interact in the
crude extract. Such compounds will be lost for further
development unless their interactions can be examined.
In order to evaluate such interactions, mostly synergis-
tic, it is necessary to know the inhibitory activity of the
crude extract and the purified fractions (i.e., their IC50
values) and the yields of extraction of the purified com-
pounds to allow calculation of their absolute quantita-
tive prevalence in the extract. Unfortunately, in most
cases, when plants are extracted and fractionated, the
activity of the crude extract is not determined and the
yields are not reported or not determined altogether.
This is the case of hundreds of thousands of purified
fractions of natural extracts that have been evaluated by
cell-based inhibition tests.
To determine the quantitative contribution of the pure
compounds to the activity of a crude extract, data from
the literature were compiled selecting those publications
in which the activities of the crude extracts and of the
purified compounds (and their yields) were reported. To
calculate the contribution of the pure active compound
to the activity of the extract, the respective IC50 values
and the yield of the purified compound are used. Data
are shown in table 1.
The equation describing the relationship between con-
centration and IC50 is:
f=max-(max-min)/(1+x/EC50)
slope where “f” is the inhibi-
tory effect. The EC50 is the IC50 of the isolated compound
and “x” is the yield-dependent calculated concentration of
* Correspondence: ericdeharo@gmail.com
1Laboratoire de Pharmacochimie des Substances Naturelles et
Pharmacophores Redox, UMR 152, UPS, Université de Toulouse, 118 Route
de Narbonne, F-31062 Toulouse cedex 9, France
Full list of author information is available at the end of the article
Deharo and Ginsburg Malaria Journal 2011, 10(Suppl 1):S5
http://www.malariajournal.com/content/10/S1/S5
© 2011 Deharo and Ginsburg; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Table 1 Compilation of data from the literature on the anti-plasmodial effects of plant extracts and their fractionated
active compounds. CS and CR are chloroquine-sensitive and –resistant strains respectively























Apocynaceae Pf K1 CR 5,7 Macrocarpamine 0,27 0,95 0,05 33,4 1
Alstonia macrophylla
Wall.
Apocynaceae Pf K1 CR 5,7 Villalstonine 0,17 0,6 0,03 31,1 2
Artemisia indica
Willd
Asteraceae Pf K1 CR 6,6 Exigua flavanones 4,6 0,15 0,01 0,4 3
Brucea javanica L.
(Merr.)
Simaroubaceae Pf K1 CR 0,5 Brucein 0,005 0,002 0,00001 0,4 4
Cryptolepis
sanguinolenta (Lindl.)
Apocynaceae Pf K1 CR 5,41 Cryptolepine 0,054 0,04 0,002 7,7 5
Diospyros sanza-
minika A. Chevalier
Ebenaceae Pf K1 CR 0,8 4-O-(3′-methylgalloyl)
norbergenin
0,6 1,2 0,01 3,1 6
Erythrina fusca Lour. Fabaceae Pf K1 CR 7,5 Citflavanone 5 0,1 0,01 0,4 7
Erythrina fusca Lour. Fabaceae Pf K1 CR 7,5 Lonchocarpol 1,6 0,2 0,02 1,9 7
Erythrina fusca Lour. Fabaceae Pf K1 CR 7,5 8-Prenyldaidzein 3,9 0,0006 0,00005 0,002 7
Garcinia cowa L. Clusiaceae Pf T9/
94CS
5 7-O-Methylgarcinone 2,5 0,01 0,00030 0,02 8
Garcinia cowa L. Clusiaceae Pf T9/
94CS
5 Cowanin 3 0,2 0,01 0,7 8
Garcinia cowa L. Clusiaceae Pf T9/
94CS
5 Cowanol 1,6 0,5 0,03 3,1 8
Garcinia cowa L. Clusiaceae Pf T9/
94CS
5 Vowaxanthone 1,5 0,4 0,02 2,6 8
Garcinia cowa L. Clusiaceae Pf T9/
94CS
5 b-Mangostin 3 0,04 0,002 0,1 8
Geissospermum
sericeum Miers










3,4 Gomphostenin-A 3,4 24 0,83 39 10
Guiera senegalensis J.
F. Gmel.











0,7 Lignan 0,12 4,5 0,03 42 12
Nauclea orientalis L. Rubiaceae Pf D6 CS 3 Oleanolic acid 4,6 0,07 0,002 0,08 13












3,7 Catechin derivatives 0,3 0,1 0,004 2,4 15
Pleiocarpa mutica
Benth.




Annonaceae Pf K1 CR 1,35 Bis-dehydroaporphine 4,1 0,16 0,002 0,1 17
Pothomorphe peltata
L.
Piperaceae Pf K1 CR 3,7 4-Nerolidylcatechol 0,21 5,7 0,21 100 18
Quassia amara L. Simaroubaceae Pf W2 CR 8,9 Simalikalactone D 0,005 0,001 0,0001 3,5 19
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the compound at the IC50 of the extract. For the simplest
case, the values are set such that max=100 and max-
min=100 and slope=1. The calculated partial effect of var-
ious compounds appears in the column captioned “% of
active compound at extract IC50”.
Taking for example the case of the crude extract of
Alstonia macrophylla and one of the most active com-
pounds, macrocarpamine: one obtains a yield for macro-
carpamine of 0.95 % and it is straightforward to
calculate that it is present in the extract at 0.054 mg at
the IC50 of the extract. Using the above equation one
gets f=16.7. Thus, the active compound contributes
16.7/50 of the overall effect or 33.4 %. Another active
compound, villalstonine, contributes 31.1 % to the
activity of the crude extract. Given the fact that there
are other active compounds in the extract, it is possible
to suggest that the effects of macrocarpamine and villal-
stonine are not synergized in the crude extract and that
their effects are additive. In such cases it can be con-
cluded that very few active compounds account for the
activity of the crude extract.
However, in the case of Garcinia cowa and 7-0-
methylgarcinone, 0.0003 mg of the compound was pre-
sent in the extract at the IC50 of the extract. The calcu-
lated f~0 and the compound contributes only 0.02 % to
the anti-plasmodial activity of the crude extract. Since
for all other purified compounds (cowanin, cowanol,
cowaxanthone and b-mangostin) the contributions
Table 1 Compilation of data from the literature on the anti-plasmodial effects of plant extracts and their fractionated
active compounds. CS and CR are chloroquine-sensitive and –resistant strains respectively (Continued)
Rhaphidophora
decursiva Schott
Araceae Pf W2 CR 6,8 Polysyphorin 0,37 0,00004 0,000003 0,001 20
Rourea minor
(Gaertn.) Alston
Connaraceae Pf W2 CR 2 Rourinoside (glycoside) 1,2 4 0,08 12,5 21
Stephania pierrei
Diels
Menispermaceae Pf W2 CR 3 Asimilobine 0,4 0,3 0,008 3,7 22
Strychnos icaja
Baillon





18 Cyclic alkyl polyol
derivatives
4,7 2,7 0,49 18,9 24
Tephrosia elata
Deflers
Fabaceae Pf D6 CS 8,4 Elatadihydrochalcone 2,8 0,2 0,02 1,1 25
Tephrosia elata
Deflers
Fabaceae Pf D6 CS 8,4 Obovatin 4,9 0,05 0,004 0,2 25
Tephrosia elata
Deflers
Fabaceae Pf D6 CS 8,4 Obovatin methyl ether 3,8 0,01 0,001 0,03 25
Tephrosia elata
Deflers















22 Coumarin 16,2 2,0 0,44 5,3 28
Vernonia brasiliana L. Asteraceae Pf BH2
CR

































10 Nitidine 1,8 6,00 0,6 50 32
Zhumeria majdae
Rech.f. & Wendelbo
Lamiaceae Pf W2 CR 7,5 12,16-dideoxy
aegyptinone B
1,4 0,6 0,05 6,2 33
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are ≤ 3.0 %, one is inclined to suggest that a strong
synergism must occur between the components. Alter-
natively and quite unlikely, the extraction procedure
destroys all the active compounds. In the extreme case
of Pothomorphe peltata all the activity of the extract is
accounted for by the activity of 4-nerolidylcatechol.
Inspection of the values that appear in the column
captioned “% of active compound at extract IC50”,
reveal that all cases can be subdivided in two groups.
In one, the contribution of active compound to
extract inhibition is ≥ ~20 %, while in the second the
values center around ~1 % or significantly lower.
Thus, in the second group considerable synergism
between active compounds must exist in order to
account for the activity of the extract, or the extrac-
tion procedure (quite unlikely) destroys the activity of
all compounds.
Among the hundreds of articles describing the anti-
plasmodial activity of plant extracts (1,031 articles were
retrieved from PubMed for the last 10 years), only very
few included the activity of the whole extract and of the
pure compounds and their respective yields of extrac-
tion. Nevertheless it is striking that for 90% of the plants
compiled in Additional file 1 the anti-malarial activity of
the purified compounds cannot account quantitatively
with that of the crude extract. If indeed this observation
reflects the reality of anti-malarial properties of plant
extracts, may be research should be focused on the
“drug beside the drug”, looking for structures perhaps
not exciting in the chemical point of view but that can
revolutionize the treatment of malaria. Another natural
consequence of this analysis is that evolution has pro-
vided not only bioactive metabolites that plants use to
fight their foes, but has also mixed them in a very auspi-
cious combination of compounds, which in some cases
also work well in mammals. To achieve a similar combi-
nation even by systematic bioguided mixing is a very
tedious, lengthy and expensive procedure. Why not
learn from nature and optimize the use of plant
extracts?
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